Center for Scientific Review Amended; Notice of Meeting, 8266 [2022-03054]

Download as PDF 8266 Federal Register / Vol. 87, No. 30 / Monday, February 14, 2022 / Notices The agenda for the March 15–16, 2022, meeting is being finalized and may include the following topics: Federal program updates; COVID–19 updates; race-concordant care, health of indigenous mothers and babies; and, the impact of violence on infant and maternal mortality. Agenda items are subject to change as priorities dictate. Refer to the ACIMM website listed above for any updated information concerning the meeting. Members of the public will have the opportunity to provide written or oral comments. Requests to submit a written statement or make oral comments to ACIMM should be sent to Anne Leitch using the email address above at least 3 business days prior to the meeting. Public participants may submit written statements in advance of the scheduled meeting by emailing SACIM@hrsa.gov. Oral comments will be honored in the order they are requested and may be limited as time allows. Individuals who plan to attend and need special assistance or some reasonable accommodation should notify Anne Leitch at the contact information listed above at least 10 business days prior to the meeting. Maria G. Button, Director, Executive Secretariat. [FR Doc. 2022–03027 Filed 2–11–22; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Health Security Strategy Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS). ACTION: Request for information. AGENCY: The Office of the Assistant Secretary for Preparedness and Response (ASPR), within the U.S. Department of Health and Human Services (HHS), is soliciting public comment regarding national health security threats, challenges, and promising practices to help inform the development of the 2023–2026 National Health Security Strategy (NHSS). Since 2006, Congress has required the Secretary of HHS to develop and submit a 4-year NHSS and implementation plan that describe ‘‘potential emergency health security threats and identify the process to be prepared to identify and respond to such threats.’’ The quadrennial NHSS is a key U.S. Government vehicle for advancing public health and medical emergency capabilities, and serves as a tool to jspears on DSK121TN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 17:54 Feb 11, 2022 Jkt 256001 address priority threats, measure progress, identify gaps, and focus action to implement national health security capabilities. DEPARTMENT OF HEALTH AND HUMAN SERVICES DATES: Comments must be received by March 11, 2022. Center for Scientific Review Amended; Notice of Meeting Comments must be submitted electronically via email to the following email address: NHSS@ hhs.gov. Instructions: Emails to NHSS@hhs.gov in response to this announcement should include ‘2023–2026 NHSS comments’ in the subject line. Responses to the Request for Information may be placed in the body of the email or in an attachment to the email using a standard document format. Request for Information: HHS/ASPR is preparing to draft the 2023–2026 NHSS. To help inform this strategy, HHS/ASPR is soliciting public comment regarding health security threats, challenges, and promising practices that may warrant being addressed in the 2023–2026 NHSS. We invite your response to the following questions. Please note that you are not limited to the questions below and we welcome additional feedback. • What are the most critical national health security threats and public health and medical preparedness, response, and recovery challenges that warrant increased attention over the next five years? • What medium-term and long-term (i.e., over next five years) actions should be taken to mitigate these challenges at the federal government and/or state, local, tribal, and territorial level? • What public health and medical preparedness, response, and recovery opportunities or promising practices should be capitalized on over the next five years? Disclaimer and Important Notes: This notice is intended for planning purposes and does not constitute a formal agreement that information from public responses will be included in the 2023– 2026 NHSS. Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel; Small Business: Biomedical Sensing, Measurement and Instrumentation Study Section, March 10–11, 2022, 9:30 a.m. to 7:00 p.m., which was published in the Federal Register on February 08, 2022, 87 FR 7194, FR DOC #2022– 02598. This meeting is being amended to change the Contact Person from Yuanna Cheng to James J. Li, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5148, MSC 7849, Bethesda, MD. The meeting dates, times, and meeting location remain the same. The meeting is closed to the public. ADDRESSES: FOR FURTHER INFORMATION CONTACT: Darrin Donato, Chief, Domestic Policy Branch, Division of Policy, Office of Strategy, Policy, Planning, and Requirements, ASPR, HHS, Washington, DC, NHSS@hhs.gov. Dawn O’Connell, Assistant Secretary for Preparedness and Response. [FR Doc. 2022–03046 Filed 2–11–22; 8:45 am] BILLING CODE 4150–37–P PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 National Institutes of Health Dated: February 8, 2022. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2022–03054 Filed 2–11–22; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Cancer Institute Council of Research Advocates. The meeting will be held as a virtual meeting and is open to the public. Individuals who plan to view the virtual meeting and need special assistance or other reasonable accommodations to view the meeting, should notify the Contact Person listed below in advance of the meeting. The meeting will be videocast and can be accessed from the NIH Videocasting and Podcasting website (https://videocast.nih.gov). Name of Committee: National Cancer Institute Council of Research Advocates. Date: March 9, 2022. Time: 12:00 p.m. to 4:15 p.m. Agenda: Welcome and Chairman’s Remarks, NCI Updates, Legislative Update, and Director’s Update. Place: National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892 (Virtual Meeting). E:\FR\FM\14FEN1.SGM 14FEN1

Agencies

[Federal Register Volume 87, Number 30 (Monday, February 14, 2022)]
[Notices]
[Page 8266]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-03054]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review Amended; Notice of Meeting

    Notice is hereby given of a change in the meeting of the Center for 
Scientific Review Special Emphasis Panel; Small Business: Biomedical 
Sensing, Measurement and Instrumentation Study Section, March 10-11, 
2022, 9:30 a.m. to 7:00 p.m., which was published in the Federal 
Register on February 08, 2022, 87 FR 7194, FR DOC #2022-02598.
    This meeting is being amended to change the Contact Person from 
Yuanna Cheng to James J. Li, Ph.D., Scientific Review Officer, Center 
for Scientific Review, National Institutes of Health, 6701 Rockledge 
Drive, Room 5148, MSC 7849, Bethesda, MD. The meeting dates, times, and 
meeting location remain the same. The meeting is closed to the public.

    Dated: February 8, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-03054 Filed 2-11-22; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.